HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma
Clinical trial NCT05290220 · UNKNOWN
Trial details
- NCT number
- NCT05290220
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-12-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.